(Q40624300)

22 September 2017

Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy (English)

1 reference

highly active antiretroviral therapy

22 September 2017

anti-retroviral agent

0 references

memory B cell

1 reference

based on heuristic

inferred from title

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14571183

23 March 2024

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

23 March 2024

author name string

Jean-Michel Fondere

1

1 reference

22 September 2017

Marie-France Huguet

2

1 reference

22 September 2017

Hans Yssel

3

1 reference

22 September 2017

Vincent Baillat

4

1 reference

22 September 2017

Jacques Reynes

5

1 reference

22 September 2017

Philippe van de Perre

6

1 reference

22 September 2017

Jean-Pierre Vendrell

7

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

22 September 2017

7 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14571183

23 March 2024

1 reference

22 September 2017

17

1 reference

22 September 2017

16

1 reference

22 September 2017

2323-2330

1 reference

Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs

22 September 2017

1

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome

23 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus

23 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects

23 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Analysis of the spontaneous in vitro anti-HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection

23 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Enhanced follicular dendritic cell-B cell interaction in HIV and SIV infections and its potential role in polyclonal B cell activation

23 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Monitoring of antibodies against human immunodeficiency virus type 1 p25 core protein as prognostic marker

23 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS.

23 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Immunoglobulin VH3 gene products: natural ligands for HIV gp120.

23 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma

23 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Loss of memory (CD27) B lymphocytes in HIV-1 infection.

23 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

B-cell immunodeficiency in acquired immune deficiency syndrome

23 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes

23 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation

23 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

HIV type 1 Tat protein induces immunoglobulin and interleukin 6 synthesis by uninfected peripheral blood mononuclear cells

23 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Nef protein of HIV-1 has B-cell stimulatory activity

23 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Effect of HIV infection on the frequency of cytokine-secreting cells in human peripheral blood

23 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy

23 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Dynamics of spontaneous HIV-1 specific and non-specific B-cell responses in patients receiving antiretroviral therapy

23 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Maturation and dispersal of B-cell clones during T cell-dependent antibody responses

23 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

23 March 2024

Germinal centers

25

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Germinal center development

23 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Human B lymphocytes: phenotype, proliferation, and differentiation

23 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

The changing preference of T and B cells for partners as T-dependent antibody responses develop

23 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

23 March 2024

Burnet's unhappy hybrid

29

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production

23 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Human IgM+IgD+ B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life.

23 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells

23 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Antiviral B cell memory in the absence of mature follicular dendritic cell networks and classical germinal centers in TNFR1-/- mice

23 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

23 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Frequencies of HIV-reactive B cells in seropositive and seronegative individuals

23 March 2024

37

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Spontaneous in vitro anti-human immunodeficiency virus type 1 antibody secretion by peripheral blood mononuclear cells is related to disease progression in zidovudine-treated adults

23 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Spontaneous monoclonal immunoglobulin-secreting peripheral blood mononuclear cells as a marker of disease severity in multiple myeloma

23 March 2024

39

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

In vitro anti-Toxoplasma gondii antibody production by peripheral blood mononuclear cells in the diagnosis and the monitoring of toxoplasmic encephalitis in AIDS-related brain lesions.

23 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease

23 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

ELISPOT: a new approach to studying the dynamics of virus-immune system interaction for diagnosis and monitoring of HIV infection

23 March 2024

44

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cells

23 March 2024

46

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response.

23 March 2024

48

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Effects of antiviral therapy on the production of anti-human immunodeficiency virus-specific immunoglobulin in infants and children

23 March 2024

49

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Journal of Acquired Immune Deficiency Syndromes

23 March 2024

50

7

641

Berberian

1994

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Identification of the B cell superantigen-binding site of HIV-1 gp120.

23 March 2024

51

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions.

23 March 2024

52

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

B-cell memory is short-lived in the absence of antigen.

23 March 2024

53

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Persistence of memory B cells in mice deprived of T cell help.

23 March 2024

55

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Memory B-cell persistence is independent of persisting immunizing antigen.

23 March 2024

56

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis

23 March 2024

57

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient

23 March 2024

58

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy

23 March 2024

59

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

23 March 2024

60

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

23 March 2024

61

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections

23 March 2024

62

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy

23 March 2024

63

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses

23 March 2024

64

1 reference

https://api.crossref.org/works/10.1097/00002030-200311070-00006

23 March 2024

Identifiers

1 reference

22 September 2017

1 reference